[Biologics and biosimilars]

Laeknabladid. 2014 May;100(5):267. doi: 10.17992/lbl.2014.05.541.
[Article in Icelandic]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biological Products / adverse effects
  • Biological Products / therapeutic use*
  • Biosimilar Pharmaceuticals / adverse effects
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Humans

Substances

  • Biological Products
  • Biosimilar Pharmaceuticals